Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
© 2024 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
生物技术企业,拥有超过 2500 例临床治疗的出色安全记录。公司设计、制造和销售亲和性血液过滤产品。一种新型高度创新的血液过滤设备,采用专利和专有的仿生技术,可 ...
这家制药公司在约旦安曼成立,已有 40 年左右的历史。 它拥有 70 多项专利,在创新方面保持着区域标杆。 作为这一创新的直接结果,通过将成熟的技术平台分拆为拥有独 ...
按“原样”计算,该农场的总面积为 72 公顷,经乌拉圭农业部 (MGAP) 授权,可种植和加工多达 60 公顷的大麻,外加 1,900 平方米用于现有温室的室内种植.目前,非精神活性大 ...
该公司在哥伦比亚市场已有 19 年的历史,拥有已获批准的 INVIMA 注册。 与一家大经销商进行了认真的对话,以将市场扩展到危地马拉和中美洲的另外 5 个国家。在哥伦比亚 ...
该公司于 1982 年在印度旁遮普省成立,目的是生产活性药物成分。 该公司是一家活性药物成分 (API) 制造公司,为制药行业的几家领先公司生产原材料,这些公司使用这些产 ...
待售医药企业,寻找最佳待售医药企业,待售医药企业市场,购买医药企业,待售医药公司,为美国企业家发现机会,待售医药公司。 浏览可立即购买的最佳待售医药业务、待售医药业务、探索待售医药业务、待售医药业务、医药业务机会。
生物技术企业,拥有超过 2500 例临床治疗的出色安全记录。公司设计、制造和销售亲和性血液过滤产品。一种新型高度创新的血液过滤设备,采用专利和专有的仿生技术,可快速清除患有血液感染的患者体内的细菌、真菌、细菌毒素、病毒、促炎细胞因子和败血症介质。
投资吸引力
全球每年有数百万患者感染败血症,病例超过 3000 万例。
该技术的其他应用可能用作生物武器攻击 (COVID)、PDAC 癌症的对策,以防止在诊断、血库和生物加工中使用 ECMO 和心肺旁路的副作用。
到 2028 年底,仅 10 倍的过去净收入就可能使公司的估值高达 400 亿美元。
增长机会
强大的管理
毛利率 >85%
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
This website is operated by MergersUS Inc a US Corporation with registered office at
报错: 未找到这个表单
报错: 未找到这个表单
报错: 未找到这个表单
报错: 未找到这个表单